Hypha Labs Inc (FUNI)

Hypha Labs, Inc. is a common stock listing on OTC Markets under the symbol FUNI. The company focuses on the research, development, and commercialization of a bioreactor in the United States. Its product portfolio includes the Hypha Micropearl bioreactor, a home appliance intended to speed up the production of beneficial mushrooms for human consumption. Hypha Labs was incorporated in 2010 and is headquartered in Las Vegas, Nevada.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-FUNI
$0.0041
-6.8% Downside
Fair
Not available
Not available
Weak
0.0%
January 14, 2027
721.142 K
2.909 M
61.6%
79.7%
-610.9
31.4%
Valuation • Fair Value

Hypha Labs Inc (OTC-FUNI) Fair Value by Valuation Model

Review the available estimates for Hypha Labs Inc (OTC-FUNI), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.0041

Estimated downside of 6.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.0041

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Hypha Labs Inc (OTC-FUNI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Hypha Labs Inc (OTC-FUNI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

-1.462 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Hypha Labs Inc (OTC-FUNI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Hypha Labs Inc (OTC-FUNI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Altman Z-Score

-610.9

Lower score that deserves closer risk review.

FCF / Net Income

31.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Hypha Labs Inc (OTC-FUNI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Hypha Labs Inc (OTC-FUNI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

January 14, 2027

Days to Earnings

114

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Hypha Labs Inc (OTC-FUNI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Hypha Labs Inc (OTC-FUNI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Hypha Labs Inc (OTC-FUNI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Hypha Labs Inc (OTC-FUNI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Hypha Labs Inc (OTC-FUNI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Hypha Labs Inc (OTC-FUNI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Hypha Labs Inc (OTC-FUNI) Stock FAQ

Data-supported answers about Hypha Labs Inc (OTC-FUNI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.0041
Estimated downside 6.8%
Valuation Rating
Overvalued
Estimated downside of 6.8%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Hypha Labs Inc (OTC-FUNI) is $0.0041. This implies an estimated downside of 6.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 6.8% versus the current market price.

The current financial health read for Hypha Labs Inc (OTC-FUNI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Hypha Labs Inc (OTC-FUNI) is January 14, 2027.

The latest available data indicates no current dividend yield for Hypha Labs Inc (OTC-FUNI).

The current market capitalization listed for Hypha Labs Inc is 721.142 K.

The current enterprise value listed for Hypha Labs Inc is 2.909 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Hypha Labs Inc is OTC-FUNI, and the stock is listed on OTC Markets.

Hypha Labs Inc (OTC-FUNI) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Hypha Labs Inc is 61.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Hypha Labs Inc is 79.7%. Free float helps investors understand how much of the share base is available for public trading.